Implementing oncology clinical trials in Nigeria: a model for capacity building
Open Access
- 3 August 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Health Services Research
- Vol. 20 (1), 1-9
- https://doi.org/10.1186/s12913-020-05561-3
Abstract
BackgroundThere is both higher mortality and morbidity from cancer in low and medium income countries (LMICs) compared with high income countries (HICs). Clinical trial activities and development of more effective and less toxic therapies have led to significant improvements in morbidity and mortality from cancer in HICs. Unfortunately, clinical trials remain low in LMICs due to poor infrastructure and paucity of experienced personnel to execute clinical trials. There is an urgent need to build local capacity for evidence-based treatment for cancer patients in LMICs.MethodsWe conducted a survey at facilities in four Teaching Hospitals in South West Nigeria using a checklist of information on various aspects of clinical trial activities. The gaps identified were addressed using resources sourced in partnership with investigators at HIC institutions.ResultsDeficits in infrastructure were in areas of patient care such as availability of oncology pharmacists, standard laboratories and diagnostic facilities, clinical equipment maintenance and regular calibrations, trained personnel for clinical trial activities, investigational products handling and disposals and lack of standard operating procedures for clinical activities. There were two GCP trained personnel, two study coordinators and one research pharmacist across the four sites. Interventions were instituted to address the observed deficits in all four sites which are now well positioned to undertake clinical trials in oncology. Training on all aspects of clinical trial was also provided.ConclusionsPartnerships with institutions in HICs can successfully identify, address, and improve deficits in infrastructure for clinical trial in LMICs. The HICs should lead in providing funds, mentorship, and training for LMIC institutions to improve and expand clinical trials in LMIC countries.Other Versions
Funding Information
- Fogarty International Center (K43 Grant Number: 1K43TW010721-01A1, D43)
- Breast Cancer Research Foundation (BCRF)
This publication has 18 references indexed in Scilit:
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- The impact of clinical research activities on communities in rural Africa: the development of the Clinical Research Unit of Nanoro (CRUN) in Burkina FasoMalaria Journal, 2014
- Building Research Capacity in Africa: Equity and Global Health CollaborationsPLoS Medicine, 2014
- Clinical trials to improve childhood cancer care and survival in sub-Saharan AfricaNature Reviews Clinical Oncology, 2013
- Neo‐adjuvant Capecitabine Chemotherapy in Women with Newly Diagnosed Locally Advanced Breast Cancer in a Resource‐poor Setting (Nigeria): Efficacy and Safety in a Phase II Feasibility StudyThe Breast Journal, 2013
- Treatment of cancer in sub-Saharan AfricaThe Lancet Oncology, 2013
- Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991–2010International Journal of Cancer, 2013
- Clinical Trials Have Gone Global: Is This a Good Thing?PLoS Medicine, 2012
- Socio-demographic factors and reasons associated with delay in breast cancer presentation: A study in Nigerian womenThe Breast, 2012
- Global Burden of Breast CancerPublished by Springer Science and Business Media LLC ,2009